A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| dolichyl-P-Man:Man6GlcNAc2-PP-dolichol α-1,2-mannosyltransferase | The formation of N-glycosidic linkages of glycoproteins involves the ordered assembly of the common Glc3Man9GlcNAc2 core-oligosaccharide on the lipid carrier dolichyl diphosphate. Early mannosylation steps occur on the cytoplasmic side of the endoplasmic reticulum with GDP-Man as donor, the final reactions from Man5GlcNAc2-PP-Dol to Man9Glc-NAc2-PP-Dol on the lumenal side use dolichyl β-D-mannosyl phosphate. ALG9 mannosyltransferase catalyses the addition of two different α-1,2-mannose residues - the addition of α-1,2-mannose to Man6GlcNAc2-PP-Dol (EC 2.4.1.259) and the addition of α-1,2-mannose to Man8GlcNAc2-PP-Dol (EC 2.4.1.261). G...Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2489; dolichyl-P-Man:Man6GlcNAc2-PP-dolichol α-1,2-mannosyltransferase; EC 2.4.1.259; ALG9; ALG9 α1,2 mannosyltransferase; dolichylphosphomannose-dependent ALG9 mannosyltransferase; ALG9 mannosyltransferase; Dol-P-Man:Man6GlcNAc2-PP-Dol α-1,2-mannosyltransferase; dolichyl β-D-mannosyl phosphate:D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?3)-D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol α-1,2-mannosyltransferase. Cat No: EXWM-2489. |  |
| dolichyl-P-Man:Man7GlcNAc2-PP-dolichol α-1,6-mannosyltransferase | The formation of N-glycosidic linkages of glycoproteins involves the ordered assembly of the common Glc3Man9GlcNAc2 core-oligosaccharide on the lipid carrier dolichyl diphosphate. Early mannosylation steps occur on the cytoplasmic side of the endoplasmic reticulum with GDP-Man as donor, the final reactions from Man5GlcNAc2-PP-Dol to Man9Glc-NAc2-PP-Dol on the lumenal side use dolichyl β-D-mannosyl phosphate. Group: Enzymes. Synonyms: ALG12; ALG12 mannosyltransferase; ALG12 α1,6mannosyltransferase. Enzyme Commission Number: EC 2.4.1.260. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2491; dolichyl-P-Man:Man7GlcNAc2-PP-dolichol α-1,6-mannosyltransferase; EC 2.4.1.260; ALG12; ALG12 mannosyltransferase; ALG12 α1,6mannosyltransferase; dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase; dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl α6-mannosyltransferase; EBS4; Dol-P-Man:Man7GlcNAc2-PP-Dol α-1,6-mannosyltransferase; dolichyl β-D-mannosyl phosphate:D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?3)-D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol α-1,6-mannosyltransferase. Cat No: EXWM-2491. | |
| dolichyl-P-Man:Man8GlcNAc2-PP-dolichol α-1,2-mannosyltransferase | The formation of N-glycosidic linkages of glycoproteins involves the ordered assembly of the common Glc3Man9GlcNAc2 core-oligosaccharide on the lipid carrier dolichyl diphosphate. Early mannosylation steps occur on the cytoplasmic side of the endoplasmic reticulum with GDP-Man as donor, the final reactions from Man5GlcNAc2-PP-Dol to Man9Glc-NAc2-PP-Dol on the lumenal side use dolichyl β-D-mannosyl phosphate. ALG9 mannosyltransferase catalyses the addition of two different α-1,2-mannose residues: the addition of α-1,2-mannose to Man6GlcNAc2-PP-Dol (EC 2.4.1.259) and the addition of α-1,2-mannose to Man8GlcNAc2-PP-Dol (EC 2.4.1.261). Gr... term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2492; dolichyl-P-Man:Man8GlcNAc2-PP-dolichol α-1,2-mannosyltransferase; EC 2.4.1.261; ALG9; ALG9 α1,2 mannosyltransferase; dolichylphosphomannose-dependent ALG9 mannosyltransferase; ALG9 mannosyltransferase; Dol-P-Man:Man8GlcNAc2-PP-Dol α-1,2-mannosyltransferase; dolichyl β-D-mannosyl phosphate:D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?6)]-D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol 2-α-D-mannosyltransferase. Cat No: EXWM-2492. | |
| dolichyl-xylosyl-phosphate-protein xylosyltransferase | This enzyme belongs to the family of glycosyltransferases, specifically the pentosyltransferases. The systematic name of this enzyme class is dolichyl-D-xylosyl-phosphate:protein D-xylosyltransferase. Group: Enzymes. Enzyme Commission Number: EC 2.4.2.33. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2661; dolichyl-xylosyl-phosphate-protein xylosyltransferase; EC 2.4.2.33. Cat No: EXWM-2661. | |
| Dolomite | Synonyms: Dolomite (CaMg(CO3)2); BR-P 3; Calcidol; Calfix; Calmag; DA 130D; DMO; DMP; DOLFL 50/90; Dolo TTS; Dolocron 32-15; Dolofil 2055; Dolofil 4085; Dolomite 90; Dolomite FM; DR 80C; DRB 30; DRB 4/21; DW 5000; GC 2; Gurhofite; Indolo 12; Indolo 8; Madol 100; MC 100B; M D 10; MD 5; MD 5 (mineral); Microdol 1; Microdol 10D; Microdol 1KN; Microdol 200; Microdol 5; Microdol 5KN; Microdol A 1; Microdol A 325; Microdol A 70; Microdol AI; Microdol CT-Ex; Microdol Extra; Microdol H 200; Microdol H 400; Microdol H 600; Microdol H Extra; Microdol M 200; Microdol Super; Microdol X; Midol 07-98; Midol 10-98; Midol MD 60; Myanit A 10; Myanit A 20; Myanit B; Myanit C; Omyadol 2RO; P 20; Saxocarb 1000; SDP 400; Sindoform K; Stradolomit A 20; Stradolomit A 40; Uwanuriyo; Virpazar. Grades: 96%. CAS No. 16389-88-1. Molecular formula: CH2O3.1/2Ca.1/2Mg. Mole weight: 184.40. |  |
| Dolomite | Dolomite. Uses: For analytical and research use. Group: Process materials, geological, cement & soils. Catalog: APS001582. Shipping: Room Temperature. |  |
| Dolomite(Calcium Magnesium Carbonate) Powder | Dolomite(Calcium Magnesium Carbonate) Powder. |  CA, FL & NJ |
| Dolomitic Limestone | Dolomitic Limestone. Uses: For analytical and research use. Group: Process materials, geological, cement & soils. Catalog: APS001585. | |
| Dolutegravir | Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. Group: Biochemicals. Alternative Names: (4R, 12aS)-N-[(2, 4-Difluorophenyl)methyl]-3, 4, 6, 8, 12, 12a-hexahydro-7-hydroxy-4-methyl-6, 8-dioxo-2H-pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxamide; GSK 1349572; S/GSK1349572. Grades: Highly Purified. CAS No. 1051375-16-6. Pack Sizes: 5mg, 10mg, 25mg. Molecular Formula: C20H19F2N3O5, Molecular Weight: 419.38. US Biological Life Sciences. |  Worldwide |
| Dolutegravir | Dolutegravir / GSK1349572 is a potent inhibitor of HIV integrase with an IC50 value of 2.7 nM for HIV-1 integrase-catalyzed strand transfer in vitro.1 It inhibits HIV-1 viral replication (EC50 = 0.51 nM) in peripheral blood mononuclear cells (PBMCs). Dolutegravir (DTG) is an antiretroviral medication used, together with other medication, to treat HIV/AIDS. It may also be used, as part of post exposure prophylaxis, to prevent HIV infection following potential exposure. Group: Fluorinated apis. Alternative Names: GSK1349572. CAS No. 1051375-16-6. Molecular formula: C20H19F2N3O5. Mole weight: 419.38. Appearance: White to off-white solid powder. Purity: >98%. IUPACName: (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide. Catalog: OFC1051375166. |  |
| Dolutegravir | Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC 50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir (S/GSK1349572) inhibits HIV-1 viral replication with an IC 50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC 50 =3.6-5.8 nM) [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: S/GSK1349572. CAS No. 1051375-16-6. Pack Sizes: 10 mM * 1 mL; 2 mg; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg; 1 g. Product ID: HY-13238. |  |
| Dolutegravir Enantiomer | Dolutegravir Enantiomer. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4S,12aR)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. CAS No. 1309560-49-3. Molecular Formula: C20H19F2N3O5. Mole Weight: 419.38. Catalog: APB1309560493. | |
| Dolutegravir (GSK1349572) | Dolutegravir is a two-metal-binding HIV-1 integrase inhibitor with IC50 of 2.7 nM, with modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. It blocks the strand transfer step of the integration of the viral genome into the host cell (INSTI). Synonyms: GSK-1349572; GSK 1349572; GSK1349572; Tivicay. Grades: ≥98%. CAS No. 1051375-16-6. Molecular formula: C20H19F2N3O5. Mole weight: 419.38. | |
| Dolutegravir Impurity 10 | Dolutegravir Impurity 10. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C28H23F4N4NaO6. Mole Weight: 610.5. Catalog: APB07650. | |
| Dolutegravir Impurity 11 | Dolutegravir Impurity 11. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-N-benzyl-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. CAS No. 2244161-71-3. Molecular Formula: C20H21N3O5. Mole Weight: 383.40. Catalog: APB2244161713. | |
| Dolutegravir Impurity 11 | Dolutegravir Impurity 11. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C14H16N2O6. Mole Weight: 308.29. Catalog: APB07651. | |
| Dolutegravir Impurity 12 | Dolutegravir Impurity 12. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-N-(2,6-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. CAS No. 2244161-72-4. Molecular Formula: C20H19F2N3O5. Mole Weight: 419.38. Catalog: APB2244161724. | |
| Dolutegravir Impurity 12 | Dolutegravir Impurity 12. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C14H16N2O6. Mole Weight: 308.29. Catalog: APB07652. | |
| Dolutegravir Impurity 13 | Dolutegravir Impurity 13. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-N-(2,4-difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxamide. Molecular Formula: C20H19F2N3O5. Mole Weight: 419.13. Catalog: APB05209. | |
| Dolutegravir Impurity 13 (Sodium Salt) | Dolutegravir Impurity 13 (Sodium Salt). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Sodium (R)-7-((2,4-difluorobenzyl)carbamoyl)-2-(4-hydroxybutan-2-yl)-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazin-9-olate. Molecular Formula: C20H18F2N3O5·Na. Mole Weight: 441.36. Catalog: APB05210. | |
| Dolutegravir Impurity 14 | Dolutegravir Impurity 14. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-3-(7-((2,4-difluorobenzyl)carbamoyl)-9-hydroxy-1,8-dioxo-1H-pyrido[1,2-a]pyrazin-2(8H)-yl)butyl 2,4-difluorobenzylcarbamate. Molecular Formula: C28H24F4N4O6. Mole Weight: 588.16. Catalog: APB05208. | |
| Dolutegravir Impurity 14 (Sodium Salt) | Dolutegravir Impurity 14 (Sodium Salt). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Sodium (R)-7-((2,4-difluorobenzyl)carbamoyl)-2-(4-(((2,4-difluorobenzyl)carbamoyl)oxy)butan-2-yl)-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazin-9-olate. Molecular Formula: C28H23F4N4O6·Na. Mole Weight: 610.49. Catalog: APB05206. | |
| Dolutegravir Impurity 15 | Dolutegravir Impurity 15. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (S)-2-(4-hydroxybutan-2-yl)-9-methoxy-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxylic acid. Molecular Formula: C14H16N2O6. Mole Weight: 308.29. Catalog: APB05207. | |
| Dolutegravir Impurity 16 | Dolutegravir Impurity 16. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-2-(4-hydroxybutan-2-yl)-9-methoxy-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxylic acid. Molecular Formula: C14H16N2O6. Mole Weight: 308.29. Catalog: APB05205. | |
| Dolutegravir Impurity 17 | Dolutegravir Impurity 17. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C20H19F2N3O5. Mole Weight: 419.38. Catalog: APB07653. | |
| Dolutegravir Impurity 18 | Dolutegravir Impurity 18. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-N-(2,4-difluorobenzyl)-7-((2,4-difluorobenzyl)amino)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. Molecular Formula: C27H24F4N4O4. Mole Weight: 544.50. Catalog: APB05204. | |
| Dolutegravir Impurity 19 | Dolutegravir Impurity 19. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-N-(5-benzyl-2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. Molecular Formula: C27H25F2N3O5. Mole Weight: 509.50. Catalog: APB05202. | |
| Dolutegravir Impurity 2 | Dolutegravir Impurity 2. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aR)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid. CAS No. 2315439-81-5. Molecular Formula: C14H16N2O6. Mole Weight: 308.29. Catalog: APB2315439815. | |
| Dolutegravir Impurity 20 | Dolutegravir Impurity 20. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. Molecular Formula: C13H15N3O5. Mole Weight: 293.28. Catalog: APB05203. | |
| Dolutegravir Impurity 21 | Dolutegravir Impurity 21. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C14H18N2O7. Mole Weight: 326.31. Catalog: APB07654. | |
| Dolutegravir Impurity 22 | Dolutegravir Impurity 22. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2,2'-((2R,2'R)-oxybis(butane-4,2-diyl))bis(9-methoxy-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxylic acid). Molecular Formula: C28H30N4O11. Mole Weight: 598.56. Catalog: APB05200. | |
| Dolutegravir Impurity 23 | Dolutegravir Impurity 23. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. CAS No. 1802141-49-6. Molecular Formula: C22H23F2N3O5. Mole Weight: 447.43. Catalog: APB1802141496. | |
| Dolutegravir Impurity 24 | Dolutegravir Impurity 24. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 3-methoxy-1-(((4S)-4-methyl-1,3-oxazinan-2-yl)methyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylic acid. Molecular Formula: C14H18N2O7. Mole Weight: 326.30. Catalog: APB05201. | |
| Dolutegravir Impurity 25 | Dolutegravir Impurity 25. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid. CAS No. 1246616-73-8. Molecular Formula: C13H14N2O6. Mole Weight: 294.09. Catalog: APB1246616738. | |
| Dolutegravir Impurity 26 | Dolutegravir Impurity 26. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1,3-bis(2,4-difluorobenzyl)urea. Molecular Formula: C15H12F4N2O. Mole Weight: 312.09. Catalog: APB05199. | |
| Dolutegravir Impurity 27 | Dolutegravir Impurity 27. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-N-(2,4-difluorobenzyl)-2-(4-hydroxybutan-2-yl)-9-methoxy-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxamide. CAS No. 2227442-13-7. Molecular Formula: C21H21F2N3O5. Mole Weight: 433.14. Catalog: APB2227442137. | |
| Dolutegravir Impurity 28 | Dolutegravir Impurity 28. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-3-(7-((2,4-difluorobenzyl)carbamoyl)-9-methoxy-1,8-dioxo-1H-pyrido[1,2-a]pyrazin-2(8H)-yl)butyl 2,4-difluorobenzylcarbamate. Molecular Formula: C29H26F4N4O6. Mole Weight: 602.18. Catalog: APB05196. | |
| Dolutegravir Impurity 29 | Dolutegravir Impurity 29. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-3-(7-((2,4-difluorobenzyl)carbamoyl)-9-hydroxy-1,8-dioxo-1H-pyrido[1,2-a]pyrazin-2(8H)-yl)butyl 1H-imidazole-1-carboxylate. Molecular Formula: C24H21F2N5O6. Mole Weight: 513.45. Catalog: APB05197. | |
| Dolutegravir Impurity 3 | Dolutegravir Impurity 3. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4S,12aR)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. Molecular Formula: C21H21F2N3O5. Mole Weight: 433.41. Catalog: APB05214. | |
| Dolutegravir Impurity 30 | Dolutegravir Impurity 30. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-3-(7-((2,4-difluorobenzyl)carbamoyl)-9-methoxy-1,8-dioxo-1H-pyrido[1,2-a]pyrazin-2(8H)-yl)butyl 1H-imidazole-1-carboxylate. Molecular Formula: C25H23F2N5O6. Mole Weight: 527.48. Catalog: APB05198. | |
| Dolutegravir Impurity 31 | Dolutegravir Impurity 31. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. Molecular Formula: C27H25F2N3O5. Mole Weight: 509.50. Catalog: APB05195. | |
| Dolutegravir Impurity 4 | Dolutegravir Impurity 4. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aR)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. Molecular Formula: C21H21F2N3O5. Mole Weight: 433.41. Catalog: APB05213. | |
| Dolutegravir Impurity 48 | Dolutegravir Impurity 48. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2374716-73-9. Molecular Formula: C20H19F2N3O5. Mole Weight: 419.38. Catalog: APB2374716739. | |
| Dolutegravir Impurity 49 | Dolutegravir Impurity 49. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1485692-21-4. Molecular Formula: C26H27F2N3O11. Mole Weight: 595.51. Catalog: APB1485692214. | |
| Dolutegravir Impurity 50 | Dolutegravir Impurity 50. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2244161-74-6. Molecular Formula: C29H26F4N4O6. Mole Weight: 602.54. Catalog: APB2244161746. | |
| Dolutegravir Impurity 52 | Dolutegravir Impurity 52. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C14H9F4N. Mole Weight: 267.23. Catalog: APB07655. | |
| Dolutegravir Impurity 7 | Dolutegravir Impurity 7. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-N-(4-fluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. CAS No. 1863916-88-4. Molecular Formula: C20H20FN3O5. Mole Weight: 401.39. Catalog: APB1863916884. | |
| Dolutegravir Impurity 8 | Dolutegravir Impurity 8. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aS)-N-(2-fluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. CAS No. 1863916-87-3. Molecular Formula: C20H20FN3O5. Mole Weight: 401.39. Catalog: APB1863916873. | |
| Dolutegravir Impurity 9 | Dolutegravir Impurity 9. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C20H18F2N3NaO5. Mole Weight: 441.37. Catalog: APB07649. | |
| Dolutegravir RR Isomer | Dolutegravir RR Isomer. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4R,12aR)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. CAS No. 1357289-29-2. Molecular Formula: C20H19F2N3O5. Mole Weight: 419.38. Catalog: APB1357289292. | |
| Dolutegravir sodium | Dolutegravir sodium salt is a HIV integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. Uses: Hiv integrase inhibitors. Synonyms: DTG; GSK1349572; GSK 1349572; GSK-1349572. Grades: >98%. CAS No. 1051375-19-9. Molecular formula: C20H18F2N3NaO5. Mole weight: 441.36. | |
| Dolutegravir sodium | Dolutegravir sodium (S/GSK1349572 sodium) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC 50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir sodium (S/GSK1349572 sodium) inhibits HIV-1 viral replication with an IC 50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir sodium (S/GSK1349572 sodium) retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC 50 =3.6-5.8 nM) [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: S/GSK1349572 sodium. CAS No. 1051375-19-9. Pack Sizes: 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-13238A. | |
| Dolutegravir (Sodium Salt) | Dolutegravir (Sodium Salt). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate. CAS No. 1051375-19-9. Molecular Formula: C20H18F2N3O5·Na. Mole Weight: 443.38. Catalog: APB1051375199. | |
| Dolutegravir SS Isomer | Dolutegravir SS Isomer. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4S,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. CAS No. 1357289-37-2. Molecular Formula: C20H19F2N3O5. Mole Weight: 419.38. Catalog: APB1357289372. | |
| Dolutevir impurity 1 | Dolutevir impurity 1. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C13H15NO7. Mole Weight: 297.26. Catalog: APB12150. | |
| Dolutevir impurity 2 | Dolutevir impurity 2. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C15H18N2O6. Mole Weight: 322.22. Catalog: APB12148. | |
| Dolutevir impurity 3 | Dolutevir impurity 3. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C25H23F2N5O6. Mole Weight: 527.48. Catalog: APB12149. | |
| Dolutevir impurity 4 | Dolutevir impurity 4. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C24H21F2N5O6. Mole Weight: 513.46. Catalog: APB12151. | |
| Domagrozumab | Domagrozumab is an anti- myostatin humanized monoclonal antibody with a K D value of 2.6 pM for human myostatin. Domagrozumab induces muscle anabolic activity. Domagrozumab can be used in research of duchenne muscular dystrophy (DMD) [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: PF-06252616. CAS No. 1629605-31-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99857. | |
| Domatinostat | Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC 50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1). Uses: Scientific research. Group: Signaling pathways. Alternative Names: 4SC-202 free base. CAS No. 910462-43-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-16012A. | |
| Domatinostat tosylate | Domatinostat tosylate (4SC-202) is a selective class I HDAC inhibitor with IC 50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1). Uses: Scientific research. Group: Signaling pathways. Alternative Names: 4SC-202. CAS No. 1186222-89-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-16012. | |
| Dominulin-A | Dominulin A has antibacterial activity. The source of Dominulin A is the social paper wasp, Polistes dominulus. Grades: >97% by HPLC. | |
| Dominulin-B | Dominulin-B shows antimicrobial activity against the Gram-positive bacteria B.subtilis, and the Gram-negative bacteria E.coli JM109 (MIC=8 μg/ml). | |
| Domiphen bromide | Cationic Detergents. Alternative Names: (Dodecyldimethyl-2-phenoxyethyl)ammonium bromide. CAS No. 538-71-6. Molecular formula: C22H40BrNO. Mole weight: 414.46. Appearance: Light yellow or white flake crystal. IUPACName: dodecyl-dimethyl-(2-phenoxyethyl)azanium;bromide. | |
| Domiphen bromide | Domiphen bromide is a chemical antiseptic and a quaternary ammonium compound, used as a cationic surfactant. Uses: Scientific research. Group: Signaling pathways. CAS No. 538-71-6. Pack Sizes: 10 mM * 1 mL; 500 mg; 5 g. Product ID: HY-B1467. | |
| Domiphen bromide | 25g Pack Size. Group: Biochemicals, Building Blocks, Quaternary Ammonium salts. Formula: C22H40BrNO. CAS No. 538-71-6. Prepack ID 79548603-25g. Molecular Weight 414.46. See USA prepack pricing. |  |
| Domiphen Bromide | Domiphen bromide is a quaternary ammonium antiseptic with actions as a cationic surfactant. Uses: Anti-infective (topical). Synonyms: NSC-39415; NSC 39415; NSC39415. Grades: >98%. CAS No. 538-71-6. Molecular formula: C22H40NO.Br. Mole weight: 414.46. | |
| Domiphen Bromide | Domiphen Bromide. Group: Biochemicals. Alternative Names: N,N-Dimethyl-N-(2-phenoxyethyl)-1-dodecanaminium Bromide (1:1); Dodecyldimethyl(2-phenoxyethyl)a mmonium Bromide; ( β -Phenoxyethyl) dimethyldodecyl Ammonium Bromide; Bradonit; Bradoral; Bradosol; Bradosol Bromide; Domiphen Bromide; Fungitex; Fungitex R; Modicare; N-Dodecyl-N- (2-phenoxyethyl) dimethylammonium Bromide; NSC 39415; Neo-Bradoral; Oradol; PDDB; Phenododecinium Bromide. Grades: Highly Purified. CAS No. 538-71-6. Pack Sizes: 2.5g. Molecular Formula: C22H40BrNO, Molecular Weight: 414.46. US Biological Life Sciences. | Worldwide |
| Domoic Acid | Domoic acid is an excitatory amino acid isolated from the red alga Chondria armata Okamura, Rhodomelaceae. Domoic acid shown to be responsible for amnesic shellfish poisoning associated with ingestion of certain cultured blue mussels. Domoic acid is a structural analog of Kainic acid.Potent agonist at receptors for excitatory amino acids glutamate and kainate; has highest affinity for AMPA/kainate receptor of any kainate agonist; causes excessive excitation of neurons leading to depletion of energy stores. Group: Biochemicals. Alternative Names: (2S,3S,4S)-2-Carboxy-4-[(1Z,3E,5R)-5-carboxy-1-methyl-1,3-hexadien-1-yl]-3-pyrrolidineacetic Acid; (-)-Domoic Acid; L-Domoic Acid; NSC 288031. Grades: Highly Purified. CAS No. 14277-97-5. Pack Sizes: 1mg, 5mg. Molecular Formula: C??H??NO?, Molecular Weight: 311.33. US Biological Life Sciences. | Worldwide |
| Domoic Acid | ≥90% (HPLC). Uses: For analytical and research use. Group: Fluorescence/luminescence spectroscopy; building blocks. CAS No. 14277-97-5. Pack Sizes: 1MG, 5MG. IUPAC Name: (2S,3S,4S)-4-[(2Z,4E,6R)-6-carboxyhepta-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid. Molecular Formula: C15H21NO6. Mole Weight: 311.33. Catalog: APS14277975. Assay: ≥90% (HPLC). SMILES: C[C@H] (\C=C\C=C (\C)/[C@H]1CN[C@@H] ([C@H]1CC (=O)O)C (=O)O)C (=O)O. Format: Neat. | |
Our database is helping our users find suppliers everyday.
